AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25816354
Drug: SQ-LNS without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SQ-LNS without zinc, placebo tablet
Trial: 25816354
Drug: SQ-LNS containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ-LNS containing 5mg zinc, placebo tablet
Trial: 25816354
Drug: SQ-LNS containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ-LNS containing 10mg zinc, placebo tablet
Trial: 25816354
Drug: SQ-LNS without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SQ-LNS without zinc and 5mg zinc tablet
Trial: 21415814
Drug: Ambulatory blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambulatory blood pressure monitoring on two occasions, 7-15 days apart, on a stable antihypertensive regimen.
Trial: 8182996
Drug: Prophylaxis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylaxis with antacids and H2 blockers (AA+H2)
Trial: 23887932
Drug: Complicated grief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complicated grief group therapy (CGGT)
Trial: 23887932
Drug: Standard group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard group therapy (treatment as usual [TAU])
Trial: 20357174
Drug: 54 mg
RxNorm normalized name: aspirin 454 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 54 mg of genistein aglycone daily (n = 71)
Trial: 11029334
Drug: 400 microgram
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microgram orally inhaled budesonide plus 200 microgram intranasal budesonide (BUD)
Trial: 11029334
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral montelukast plus 10 mg oral cetirizine (ML + CZ)
Trial: 8610727
Drug: Subcutaneous administration
RxNorm normalized name: subcutaneous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous administration (usual dose)
Trial: 8610727
Drug: Subcutaneous administration
RxNorm normalized name: subcutaneous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous administration (1.75-fold dose)
Trial: 8610727
Drug: Implantable pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable pump therapy (1.75-fold dose)
Trial: 8610727
Drug: Implantable pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable pump therapy (usual dose)
Trial: 3914839
Drug: Tamoxifen (secondary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (secondary therapy)
Trial: 3914839
Drug: Estrogen (secondary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen (secondary therapy)
Trial: 3695527
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with Dacarbazine (DTIC) 200 mg/M2 I.V. daily X 5 every 4 weeks and Estracyt 15 mg/kg orally daily for 1 year
Trial: 3695527
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with TICE BCG 1 ml to an area of scarification near the primary site, every 4 weeks for 1 year
Trial: 17024871
Drug: Postoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiation therapy (PORT)
Trial: 12137243
Drug: Inhalation challenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation challenge with (1‐‐>3)‐beta‐D‐glucan
Trial: 12137243
Drug: Saline inhalation
RxNorm normalized name: Broncho Saline Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline inhalation challenge
Trial: 29119296
Drug: Steroid injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid injection (1 ml of Depo-Medrol, 40 mg)
Trial: 18672763
Drug: Shexiang Baoxin
RxNorm normalized name: CAMPHOR (NATURAL) 30.53 mg / MENTHOL 40.71 mg / METHYL SALICYLATE 25.95 mg TOPICAL PLASTER [SheXiang ZhuangGu Gao]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shexiang Baoxin Pill (SBP) 2 pills, taken orally three times per day for 6 months
Trial: 18672763
Drug: Basic therapy
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic therapy for CHD (anti-platelet, lipid regulating, anti-ischemia)
Trial: 16898535
Drug: Steroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid treatment (60 mg/m2/48h) in children in relapse (Group A, n=24)
Trial: 16898535
Drug: Steroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid treatment (30 mg/m2/48h) in children in remission (Group B, n=20)
Trial: 16898535
Drug: No steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No steroid treatment in children in remission (Group C, n=22)
Trial: 2011407
Drug: Ciprofloxacin (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (750 mg b.i.d.)
Trial: 2011407
Drug: Amoxicillin +
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin + clavulanic acid or erythromycin
Trial: 24249544
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose trivalent inactivated influenza vaccine (60 µg)
Trial: 24249544
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose trivalent inactivated influenza vaccine (15 µg)
Trial: 22017808
Drug: Mindfulness-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based cognitive therapy plus treatment as usual (MBCT+TAU)
Trial: 11910270
Drug: Metergoline 8
RxNorm normalized name: Metergoline
DrugBank: Metergoline (DB13520)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metergoline 8 mg
Trial: 11910270
Drug: Bright artificial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright artificial light treatment after 2 weeks
Trial: 18158176
Drug: Specific oral
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific oral tolerance induction (SOTI)
Trial: 3593481
Drug: Acute alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute alcohol consumption (0.4 g/kg orally)
Trial: 3593481
Drug: Standard (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard (75 g) glucose tolerance test
Trial: 27697397
Drug: 2 implant‐supported‐overdentures
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 implant‐supported‐overdentures on two tissue‐level implants
Trial: 27697397
Drug: 4 implant‐supported‐overdentures
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 implant‐supported‐overdentures on four tissue‐level implants
Trial: 24818861
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural treatment programme (CONECSI)
Trial: 22566279
Drug: Group acceptance
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group acceptance and commitment therapy (ACT) informed stress management intervention
Trial: 16485515
Drug: Perindopril 8
RxNorm normalized name: perindopril 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 8 mg/day for 1 year
Trial: 9279673
Drug: Flurbiprofen 0.03%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 0.03% ophthalmic solution
Trial: 9279673
Drug: Indomethacin 1.0%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 1.0% ophthalmic solution
Trial: 24998653
Drug: Atorvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (20 mg q.d for 1 year)
Trial: 22402864
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 20 mg/kg/day for 12 months
Trial: 11248182
Drug: Cytokine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine therapy (growth factor treatment)
Trial: 26081328
Drug: Ibuprofen (200-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (200-400 mg/day) + Tizanidine (2-4 mg/day) + Anvifen (750 mg/day) for 8 weeks
Trial: 26081328
Drug: Ibuprofen (200-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (200-400 mg/day) + Tizanidine (2-4 mg/day)
Trial: 25040039
Drug: AQX-1125 (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AQX-1125 (450 mg daily)
Trial: 19916252
Drug: Ropivacaine 0.375%
RxNorm normalized name: ROPivacaine 0.375%-NaCl 0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.375% (20 mL)
Trial: 19916252
Drug: Placebo (saline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline, 20 mL)
Trial: 20088941
Drug: Acarbose up
RxNorm normalized name: Acarbose
DrugBank: Acarbose (DB00284)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acarbose up to 100 mg three times a day
Trial: 11598842
Drug: Yeast-derived HPV-11
RxNorm normalized name: YEAST CELL,LIVE DERIVATIVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yeast-derived HPV-11 L1 VLP vaccine
Trial: 2846132
Drug: Propranolol 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 320 mg daily
Trial: 2846132
Drug: Propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 80 mg daily
Trial: 27236150
Drug: Telaprevir-based triple
RxNorm normalized name: Telaprevir
DrugBank: Telaprevir (DB05521)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Telaprevir-based triple therapy
Trial: 17509246
Drug: Disease-modifying drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease-modifying drugs
Trial: 14711840
Drug: Linezolid (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid (600 mg/12 h)
Trial: 14711840
Drug: Teicoplanin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin (400 mg/12 h for three doses then 400 mg/24 h)
Trial: 8103027
Drug: Ranitidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine infusion (up to 600 mg/24 hours)
Trial: 30595526
Drug: JR‐141 (iduronate-2-sulfatase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JR‐141 (iduronate-2-sulfatase fused with anti-human transferrin receptor antibody)
Trial: 27422891
Drug: Toreforant 100
RxNorm normalized name: Toreforant
DrugBank: Toreforant (DB12522)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toreforant 100 mg/day
Trial: 27422891
Drug: Toreforant 3/10/30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toreforant 3/10/30 mg
Trial: 18042508
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy (ART) with 3 agents for 48 weeks
Trial: 12133187
Drug: Physiological-dose steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological-dose steroid therapy for 10 days
Trial: 7540397
Drug: Low-dose aprotinin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose aprotinin (30,000 KIU/kg in CPB priming volume and 7,500 KIU/kg intravenously each hour during CPB)
Trial: 2228396
Drug: dexfenfluramine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexfenfluramine (30 mg/day)
Trial: 31658479
Drug: Interventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interventional treatment strategies for secondary MR
Trial: 28148502
Drug: Intragastric administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intragastric administration of 1 μmol DB/kg
Trial: 16904537
Drug: Caffeine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (10 mg/l)
Trial: 15167288
Drug: Triple-nucleoside therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-nucleoside therapy (ZDV, 3TC, and ddI)
Trial: 15167288
Drug: Dual-nucleoside therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-nucleoside therapy (ZDV and 3TC or ddI and d4T)
Trial: 2885337
Drug: Insulin alone
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin alone (25 mU/m2 X min)
Trial: 2885337
Drug: Insulin with
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin with SRIH (250 micrograms/h) and glucagon replacement (0.4 ng/kg X min)
Trial: 30255302
Drug: Simvastatin (Zocor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (Zocor – MSD; 40 mg daily)
Trial: 29626465
Drug: 12-month adjuvant
RxNorm normalized name: moth bean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-month adjuvant androgen-deprivation therapy (ADT)
Trial: 25391138
Drug: Ferrous gluconate
RxNorm normalized name: Ferrous Gluconate
DrugBank: Ferrous gluconate (DB14488)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous gluconate in a capsule
Trial: 25391138
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cola jelly and calcium
Trial: 9386673
Drug: RRV‐TV (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRV‐TV (4 x 10(5) plaque‐forming units per dose)
Trial: 9386673
Drug: RRV‐S1 (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRV‐S1 (4 x 10(5) plaque‐forming units per dose)
Trial: 22411021
Drug: Monthly automated
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly automated telephone calls reminding to take glaucoma medications and a 1-time educational session with a physician.
Trial: 16132877
Drug: ML-1 standardized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ML-1 standardized mistletoe extract (1 ng/kg body weight, injected subcutaneously twice weekly for 60 weeks)
Trial: 10910490
Drug: remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: remifentanil infusion titrated to autonomic responses
Trial: 8764802
Drug: Placebos (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebos (oral and intravenous)
Trial: 1395837
Drug: BBPRI vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BBPRI vaccine
Trial: 1395837
Drug: BBPRI vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BBPRI vaccine plus HBIG
Trial: 12916869
Drug: Iseganan 9
RxNorm normalized name: Iseganan
DrugBank: Iseganan (DB16010)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iseganan 9 mg, oral rinse, swished/swallowed 6 times daily for 21-28 days
Trial: 12916869
Drug: Placebo, oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, oral rinse, swished/swallowed 6 times daily for 21-28 days
Trial: 10617707
Drug: Midazolam nasal
RxNorm normalized name: midazolam Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam nasal spray (0.2 mg/kg body weight)
Trial: 8885584
Drug: Methylphenidate (individual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (individual titration to 'best' dose)
Trial: 3878631
Drug: Combination therapies
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapies including Sucralfate
Trial: 25932849
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g cefazolin
Trial: 25932849
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g cefazolin
Trial: 17407626
Drug: paroxetine 40
RxNorm normalized name: PARoxetine 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: paroxetine 40 mg/day
Trial: 15159237
Drug: Fruveg group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fruveg group (600 g fruit and vegetables/d)
Trial: 15159237
Drug: Supplement group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplement group (vitamin pill corresponding to 600 g fruit and vegetables)
Trial: 15159237
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (placebo pill)
Trial: 15159237
Drug: Supplement group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplement group
Trial: 15159237
Drug: Fruveg group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fruveg group and Supplement group
Trial: 16967629
Drug: Unopposed E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unopposed E2 1 mg
Trial: 10960628
Drug: E2-norethindrone acetate
RxNorm normalized name: Norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: E2-norethindrone acetate 0.1 mg
Trial: 10960628
Drug: E2-norethindrone acetate
RxNorm normalized name: Norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: E2-norethindrone acetate 0.25 mg
Trial: 10960628
Drug: E2-norethindrone acetate
RxNorm normalized name: Norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: E2-norethindrone acetate 0.5 mg
Trial: 1310645
Drug: Soya fibers
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soya fibers (7 g)
Trial: 1310645
Drug: Cellulose (7
RxNorm normalized name: ethylcellulose (7 MPA.S)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cellulose (7 g)
Trial: 6239881
Drug: compound tincture
RxNorm normalized name: Compound tincture benzoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: compound tincture of benzoin
Trial: 26797802
Drug: Imatinib therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib therapy
Trial: 27751589
Drug: 7.5mg oral
RxNorm normalized name: Iron 37.5mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5mg oral paroxetine
Trial: 22421064
Drug: Augmentation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmentation with olanzapine (RIS+OLZ group)
Trial: 22421064
Drug: Increased risperidone
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Increased risperidone dose (RIS+RIS group)
Trial: 16192774
Drug: Intravenous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous treatment (lidocaine-sufentanil-clonidine)
Trial: 16192774
Drug: Postoperative epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative epidural treatment (intravenous-epidural)
Trial: 16192774
Drug: Intraoperative epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative epidural treatment (epidural-epidural and epidural-intravenous)
Trial: 12519409
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated equine oestrogens
Trial: 12519409
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta‐oestradiol
Trial: 12519409
Drug: Oral 17
RxNorm normalized name: polyoxypropylene (17)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 17 beta‐oestradiol followed by sequential oestrogen‐progestogen HRT (17 beta‐oestradiol and dydrogesterone)
Trial: 10759926
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A, 100 units, diluted in 1 mL of saline
Trial: 10759926
Drug: Saline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (1 mL)
Trial: 8641826
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of oral zinc sulfate once daily for 24 months
Trial: 28911062
Drug: TPF-E (cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPF-E (cisplatin and docetaxel 75mg/m2 on day 1 followed by 5-FU 750mg/m2/day as a continuous infusion on days 1-5 plus cetuximab at a loading dose of 400mg/m2 followed by a weekly dose of 250mg/m2)
Trial: 28911062
Drug: Weekly cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly cisplatin 40mg/m2
Trial: 28911062
Drug: Weekly carboplatin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly carboplatin, AUC of 1.5mg/ml/min
Trial: 28911062
Drug: Radiotherapy (70Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy (70Gy over 7 weeks in 2Gy fractions) with weekly cetuximab
Trial: 26031148
Drug: Methotrexate monotherapy
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate monotherapy (5-20 mg weekly)
Trial: 15741251
Drug: Ganirelix (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganirelix (selective GnRH-receptor antagonist)
Trial: 9804024
Drug: Cochlear implants
RxNorm normalized name: Cochlearia officinalis leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cochlear implants (CI), post-operative period
Trial: 7614643
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg plus sodium citrate